Batroxobin: Difference between revisions
CSV import |
CSV import |
||
| Line 23: | Line 23: | ||
{{stub}} | {{stub}} | ||
== Batroxobin gallery == | |||
<gallery> | |||
File:P04971 homology model thrombin-like enzyme batroxobin.png|Homology model of thrombin-like enzyme batroxobin | |||
</gallery> | |||
Latest revision as of 05:43, 3 March 2025
Batroxobin is a hemostatic enzyme that is derived from the venom of the Bothrops atrox snake, also known as the fer-de-lance. It is used in medicine to promote blood clotting and to treat certain blood disorders.
History[edit]
Batroxobin was first isolated from the venom of the Bothrops atrox snake in the 1930s. It was initially used in South America to treat snakebite victims, but its use has since expanded to other areas of medicine.
Medical uses[edit]
Batroxobin is used in medicine to promote blood clotting. It works by converting fibrinogen into fibrin, which is the protein that forms the framework of a blood clot. This makes it useful in treating conditions that involve excessive bleeding, such as hemophilia and von Willebrand disease.
In addition to its hemostatic properties, batroxobin has also been found to have anti-inflammatory effects. This makes it potentially useful in treating conditions that involve inflammation, such as rheumatoid arthritis and osteoarthritis.
Side effects[edit]
Like all medicines, batroxobin can cause side effects. These can include allergic reactions, nausea, vomiting, and pain at the injection site. In rare cases, it can cause serious side effects such as anaphylaxis and thrombosis.
